The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide
Open accessAbstract
The development of type II diabetes was shown to be associated with the formation of amyloid fibrils consisted of the islet amyloid polypeptide (IAPP or amylin). Recently, a short functional hexapeptide fragment of IAPP (NH(2)-NFGAIL-COOH) was found to form fibrils that are very similar to those formed by the full-length polypeptide. To better understand the specific role of the residues that compose the fragment, we performed a systematic alanine scan of the IAPP "basic amyloidogenic units." Turbidity assay experiments demonstrated that the wild-type peptide and the Asn(1) --> Ala and Gly(3) --> Ala peptides had the highest rate of aggregate formation, whereas the Phe(2) --> Ala peptide did not form any detectable aggregates. Dynamic light-scattering experiments demonstrated that all peptides except the Phe(2) --> Ala form large multimeric structures. Electron microscopy and Congo red staining confirmed that the structures formed by the various peptides are indeed amyloid fibrils. Taken together, the results of our study provide clear experimental evidence for the key role of phenylalanine residue in amyloid formation by IAPP. In contrast, glycine, a residue that was suggested to facilitate amyloid formation in other systems, has only a minor role, if any, in this case. Our results are discussed in the context of the remarkable occurrence of aromatic residues in short functional fragments and potent inhibitors of amyloid-related polypeptides. We hypothesize that pi-pi interactions may play a significant role in the molecular recognition and self-assembly processes that lead to amyloid formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
McGaughey, G. B., Gagné, M., & Rappé, A. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15458 · Cited by 1,160
Review: History of the Amyloid Fibril
Sipe, J. D., & Cohen, A. S. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4221 · Cited by 1,054
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand
Tjernberg, L. O., Näslund, J., Lindqvist, F., Johansson, J., Karlström, A. R., Thyberg, J., Terenius, L., & Nordstedt, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8545 · Cited by 963
Prusiner, S. B., Scott, M. R., DeArmond, S. J., & Cohen, F. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81163-0 · Cited by 923
Soto, C., Sigurdsson, E. M., Morelli, L., Asok Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 876
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807
Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast
Patino, M. M., Liu, J.-J., Glover, J. R., & Lindquist, S. (1996) · Science · doi:10.1126/science.273.5275.622 · Cited by 611
Gurd, A., & Wilson, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91669-8 · Cited by 526
Islet Amyloid and Type 2 Diabetes Mellitus
Höppener, J. W. M., Ahrén, B., & Lips, C. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008103430607 · Cited by 521
Westermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 512
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn, S. E., Andrikopoulos, S., & Verchere, C. B. (1999) · Diabetes · doi:10.2337/diabetes.48.2.241 · Cited by 488
Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M., Weber, M., Merkle, M.-L., Voelter, W., Brunner, H., & Kapurniotu, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3422 · Cited by 426
Arene—Arene Interactions: Electrostatic or Charge Transfer?
Hunter, C. A. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199315841 · Cited by 377
Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in Vitro
Kayed, R., Bernhagen, J., Greenfield, N., Sweimeh, K., Brunner, H., Voelter, W., & Kapurniotu, A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2646 · Cited by 351
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 350
Jarrett, J. T., & Lansbury, P. T. (1992) · Biochemistry · doi:10.1021/bi00164a008 · Cited by 325
Amyloid Fibril Formation from Full-Length and Fragments of Amylin
Goldsbury, C., Goldie, K., Pellaud, J., Seelig, J., Frey, P., Müller, S. A., Kistler, J., Cooper, G. J. S., & Aebi, U. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4268 · Cited by 316
Westermark, P., Wernstedt, C., O’Brien, T. D., Hayden, D. W., & Johnson, K. H. (1987) · PubMed · Cited by 261
Wisniewski, T., Ghiso, J., & Frangione, B. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91706-i · Cited by 249
Electron Microscopy of Proteins
SHOTTON, D. (1982) · Biochemical Society Transactions · doi:10.1042/bst0100438b · Cited by 241
Modified-Peptide Inhibitors of Amyloid β-Peptide Polymerization
Findeis, M. A., Musso, G. M., Arico-Muendel, C. C., Benjamin, H. W., Hundal, A. M., Lee, J.-J., Chin, J., Kelley, M., Wakefield, J., Hayward, N. J., et al. (1999) · Biochemistry · doi:10.1021/bi982824n · Cited by 222
Häggqvist, B., Näslund, J., Sletten, K., Westermark, G. T., Mucchiano, G., Tjernberg, L. O., Nordstedt, C., Engström, U., & Westermark, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8669 · Cited by 221
Recognition Sequence Design for Peptidyl Modulators of β-Amyloid Aggregation and Toxicity
Pallitto, M. M., Ghanta, J., Heinzelman, P., Kiessling, L. L., & Murphy, R. M. (1999) · Biochemistry · doi:10.1021/bi982119e · Cited by 210
Effects of Sequential Proline Substitutions on Amyloid Formation by Human Amylin20-29
Moriarty, D. F., & Raleigh, D. P. (1999) · Biochemistry · doi:10.1021/bi981658g · Cited by 201
The de novo design of protein structures
Richardson, J. S., & Richardson, D. C. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90070-4 · Cited by 184
Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization
Findeis, M. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00034-x · Cited by 174
Lansbury, P. T. (1992) · Biochemistry · doi:10.1021/bi00145a001 · Cited by 165
Sipe, J. D., & Cohen, A. S. (1994) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369409084679 · Cited by 165
Aromatic van der Waals Clusters: Structure and Nonrigidity
Sun, S., & Bernstein, E. R. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp960739o · Cited by 150
Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
Kapurniotu, A., Bernhagen, J., Greenfield, N. J., Al‐Abed, Y., Teichberg, S., Frank, R. W., Voelter, W., & Bucala, R. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510208.x · Cited by 111
Structure and biology of amylin
RINK, T. J., Beaumont, K. C., Koda, J. E., & Young, A. W. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90081-t · Cited by 105
Abnormal Properties of Prion Protein with Insertional Mutations in Different Cell Types
Priola, S. A., & Chesebro, B. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11980 · Cited by 88
Clements, A., Walsh, D. M., Williams, C. H., & Allsop, D. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90129-9 · Cited by 83
Yeast Prions and Their Prion-Forming Domain
Tuite, M. F. (2000) · Cell · doi:10.1016/s0092-8674(00)80663-7 · Cited by 75
Ashburn, T. T., & Lansbury, P. T. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00076a078 · Cited by 71
Kuner, P., Bohrmann, B., Tjernberg, L. O., Näslund, J., Huber, G., Celenk, S., Grüninger-Leitch, F., Richards, J. G., Jakob-Rœtne, R., Kemp, J. A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1673 · Cited by 70
Twyman, L. J., & Allsop, D. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)02030-4 · Cited by 56
Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry
Larson, J. L., Ko, E. C., & Miranker, A. D. (2000) · Protein Science · doi:10.1110/ps.9.2.427 · Cited by 49
Cited by
Casting Metal Nanowires Within Discrete Self-Assembled Peptide Nanotubes
Reches, M., & Gazit, E. (2003) · Science · doi:10.1126/science.1082387 · Cited by 2,530
Self-citationA possible role for π‐stacking in the self‐assembly of amyloid fibrils
Gazit, E. (2002) · The FASEB Journal · doi:10.1096/fj.01-0442hyp · Cited by 1,133
Self-citationRationalization of the effects of mutations on peptide andprotein aggregation rates
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., & Dobson, C. M. (2003) · Nature · doi:10.1038/nature01891 · Cited by 1,072
AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides
Conchillo-Solé, O., de Groot, N. S., Avilés, F. X., Vendrell, J., Daura, X., & Ventura, S. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-65 · Cited by 1,068
Porat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
Self-citation
Metadata
- Authors
- Azriel, R., & Gazit, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 276
- Issue
- 36
- Pages
- 34156-34161
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044597283
- Cited by
- 420
- References
- 45
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.